UAE Health Check-up Market Set for Robust Growth Driven by Preventive Healthcare Initiatives

 

The UAE health check-up market is on a strong growth trajectory, projected to reach US$ 113.8 million by 2032, up from US$ 77.0 million in 2025, reflecting a compound annual growth rate (CAGR) of around 5.0% during the forecast period. This growth reflects a notable transformation in the UAE’s healthcare landscape, where residents are increasingly shifting from reactive treatment approaches to proactive, preventive care. Regular health check-ups are now being recognized as essential components of personal well-being rather than optional services. The growing focus on lifestyle disease management, government-led health campaigns, mandatory screenings for residency and employment, and innovative diagnostic technologies are driving this trend, particularly in urban hubs like Abu Dhabi and Dubai.

Key Industry Highlights

General health check-ups are expected to hold a dominant share in 2025, driven by the adoption of wellness programs among corporates. Companies are increasingly incorporating regular screenings to minimize absenteeism and control insurance-related expenditures. Blood glucose tests are anticipated to account for approximately 22.6% of the market share in 2025, reflecting national campaigns aimed at raising awareness of diabetes and encouraging screening participation. Abu Dhabi is poised to command a substantial share, thanks to strong public-private partnerships, including collaborations between SEHA and Mubadala Health, which expand access to advanced diagnostic services. Mandatory medical screenings tied to visa and employment regulations further bolster the routine uptake of health check-ups. Additionally, investments in digital health platforms are creating scalable models for remote and tech-enabled screenings, enhancing the accessibility of preventive healthcare across the UAE.

Market Overview and Growth Dynamics

The UAE health check-up market was valued at US$ 77.0 million in 2025 and is expected to grow to US$ 113.8 million by 2032, marking a CAGR of 5.0%. Historically, the market witnessed a CAGR of 4.2% between 2019 and 2024. This upward trend is primarily driven by government campaigns promoting preventive healthcare, residency and employment health requirements, and the adoption of digital health solutions.

Market Drivers

Proactive health management is increasingly being prioritized in the UAE, reflecting a cultural shift toward early intervention and disease prevention. Government initiatives have played a critical role in this transformation. In November 2023, the UAE Ministry of Health and Prevention launched a nationwide campaign offering free diabetes screenings to Emirati residents. Such programs encourage individuals to monitor their health and facilitate early detection of chronic conditions.

Mandatory medical screenings for residency and employment further reinforce market growth. All foreign nationals aged 18 and above are required to undergo medical fitness tests to obtain or renew residence visas. These screenings test for communicable diseases such as hepatitis B and C, leprosy, tuberculosis, and HIV. Specific professions, including healthcare personnel, food handlers, and domestic workers, require additional screenings, such as pregnancy and syphilis tests for women. These regulations have established routine health check-ups as a norm in the UAE.

Market Restraints

Despite robust growth, the market faces challenges from the overutilization of diagnostic tests and high expatriate turnover in the healthcare workforce. Expatriates constitute the majority of healthcare staff in the UAE, with 96% in Abu Dhabi and 90% in Dubai, according to a study published in Global Health by NCBI. High turnover disrupts continuity of care and strains healthcare infrastructure, complicating consistent delivery of health check-up services.

The overuse of certain diagnostic tests, including autoimmune disease testing and rapid influenza diagnostics, poses another challenge. Driven in part by financial incentives, over-diagnosis has been reported in private healthcare facilities, primarily targeting patients with comprehensive insurance plans. This trend raises healthcare costs and exposes patients to unnecessary interventions. Authorities like the Dubai Health Authority are implementing regulatory measures to curb over-treatment and fraudulent practices.

Market Opportunities

The UAE’s emphasis on genomics and personalized medicine presents significant opportunities for the health check-up market. The Emirati Genome Program, a joint initiative between Abu Dhabi’s G42 and Mubadala, has sequenced over 800,000 genomes, including 702,000 Emirati genomes, establishing one of the largest national genomic databases worldwide. This resource allows healthcare providers to identify genetic predispositions to conditions such as cardiovascular disease, cancer, and diabetes, enabling predictive and customized screenings. Individuals at high genetic risk can participate in targeted monitoring programs, facilitating early detection and preventive interventions.

Category-wise Analysis

Check-up Type Insights

The UAE health check-up market is categorized into general, preventive, specialized, and routine wellness check-ups. General health check-ups are expected to dominate in 2025 due to the rising prevalence of chronic conditions. The UAE National Cancer Registry reports over 4,000 new cancer cases annually, with a crude incidence rate of 46.1 per 100,000 individuals. General assessments, including BMI evaluation, blood pressure monitoring, and blood tests, serve as essential tools for early detection and management.

Specialized health check-ups are projected to witness significant growth from 2025 to 2032. Advanced diagnostic tools, such as imaging-based tests, have increased screening efficiency and accuracy. These technologies are particularly useful for early detection of cancers and cardiovascular diseases, supporting the growing demand for specialized health services.

Body Test Insights

The market for body tests includes blood glucose, kidney function, bone profile, lipid profile, electrolytes, liver function, special biochemistry, and others. Blood glucose testing is expected to represent 22.6% of market share in 2025, driven by the high prevalence of diabetes and pre-diabetes among the UAE population. According to the International Diabetes Federation, diabetes affects 16.3% of UAE residents, significantly higher than the global average of 9.3%. Early screening and intervention are critical, increasing demand for these tests.

Tumor marker testing is also expected to capture a significant share, reflecting rising cancer incidence and the adoption of personalized medicine. Tumor marker tests enable early diagnosis and monitoring of cancers by detecting proteins or substances produced by cancer cells. Innovations such as liquid biopsies provide non-invasive monitoring options, reducing risks and discomfort associated with conventional procedures.

Emirate-wise Insights

Abu Dhabi

Abu Dhabi is projected to hold approximately 32.8% of the health check-up market in 2025. The emirate has witnessed a surge in preventive care initiatives, personalized wellness programs, and digital health adoption. Physical activity levels among residents have increased, with 53% meeting WHO-recommended standards, up from 36% previously. International patient volumes at Cleveland Clinic Abu Dhabi rose by 35% in 2024, emphasizing the emirate’s global reputation for specialized healthcare services. AI-assisted genomic and imaging diagnostics are being utilized to enhance screening accuracy and efficiency.

Sharjah

Sharjah is expected to experience steady market growth due to community outreach and occupational health programs. The MoHAP, in partnership with the Sharjah Supreme Council for Family Affairs, launched the “Your Safety Is Our Goal” campaign in 2024, providing free health check-ups to over 6,000 outdoor workers. Additionally, the 10th edition of the My Health Conference highlighted initiatives targeting mental health, nutrition, and physical activity, underscoring Sharjah’s commitment to public health awareness.

Dubai

In Dubai, corporate wellness programs are expanding to include preventive healthcare, nutrition guidance, and mental health support. Leading companies allocate 2–5% of their annual budgets to employee health initiatives. Dubai’s prominence as a medical tourism destination further drives demand for advanced diagnostics. Dubai Healthcare City hosts over 90 diagnostic centers processing more than 4.5 million tests annually. The Dubai Health Authority’s 2023 budget dedicated 20% to laboratory infrastructure and diagnostics, reflecting continued investment in healthcare services.

Competitive Landscape

The UAE health check-up market comprises digital health start-ups, specialized diagnostic centers, and private hospitals. Key players offer comprehensive check-up packages that integrate lifestyle consultations with diagnostic services. Start-ups are leveraging telehealth, home sample collection, and AI-driven diagnostics to enhance accessibility. Government initiatives promoting preventive care have intensified competition among providers, encouraging investment in international accreditation, patient engagement apps, and advanced diagnostics.

Key Industry Developments

In May 2025, Abu Dhabi Public Health Center and the Authority of Social Contribution - Ma’an launched a fundraising initiative to enhance early screening for diabetes, cardiovascular diseases, and cancer among basic health insurance holders. In April 2025, FP7McCann Dubai partnered with the Testicular Cancer Society to introduce the Amateur Anti-Doping Test, transforming routine athlete screenings into cancer detection programs. In January 2025, MoHAP announced the introduction of AI-based Biosigns technology, enabling individuals to monitor key health indicators via smartphones and tablets.

Companies Covered

Key market participants include Quest Diagnostics Incorporated, OPKO Health Inc., Laboratory Corporation of America Holdings, UNILABS, SYNLAB International GmbH, Sonic Healthcare Limited, Q2 Solutions, ARUP Laboratories, Eurofins Scientific, among others. These players are expanding service portfolios and leveraging digital innovations to strengthen market positioning and cater to growing demand for preventive healthcare in the UAE.

The UAE health check-up market is poised for sustained growth, driven by proactive healthcare approaches, government initiatives, technological advancements, and rising public awareness. With an evolving focus on personalized screenings, corporate wellness, and digital health solutions, the market is transforming preventive healthcare into an essential aspect of life for residents across the Emirates.